Target intelligence / Profile preview

Lysine rich nucleolar protein 1 pseudogene 2 (KNOP1P2)

Target
KNOP1P2
Molecular classification
Pseudogene
01

Overview

**Lysine rich nucleolar protein 1 pseudogene 2 (KNOP1P2)** is a human pseudogene, a DNA sequence resembling a functional gene but generally considered nonfunctional in terms of protein-coding potential. Pseudogenes typically arise from duplication or retrotransposition events and accumulate disabling mutations that prevent their normal expression or translation. KNOP1P2 has no known biological, enzymatic, signaling, or disease-related function, and is not considered a therapeutic target. Pseudogenes like KNOP1P2 may occasionally serve regulatory roles in RNA biology, but there is no evidence for such a role in this specific pseudogene[1][3]. **Context and supporting details:** - Pseudogenes are, by definition, not functional protein-coding genes and are not considered drug targets, enzymes, receptors, or transporters[1]. - KNOP1P2 is classified as a pseudogene in multiple genomic databases and is not associated with any molecular function, phenotype, or disease[3]. - There are no known drugs, biomarkers, or disease associations connected to KNOP1P2. - No evidence suggests it encodes a functional non-coding RNA. Thus, **KNOP1P2 is both not a therapeutic target and likely represents a nonfunctional genomic element**. Its inclusion as a "target" would generally be considered incorrect in standard biomedical contexts.

Other names
KNOP1P2

Beyond the preview

Go deeper on Lysine rich nucleolar protein 1 pseudogene 2 (KNOP1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine rich nucleolar protein 1 pseudogene 2 (KNOP1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call